Multimaterial encapsulation technology for controlled release
Explore advanced multimaterial encapsulation technology driven by electric and non-electric fields, capable of controlled release. This scalable solution has applications in pharmaceuticals, food technology, and more, enabling precise delivery of various payloads.
Overview
This novel multimaterial encapsulation technology utilizes both electric field and non-electric field driven approaches to create single to multi-compartmental encapsulations. These encapsulations are designed with molecular gates that allow for controlled release of immobilized payloads. The technology holds significant potential for applications in pharmaceuticals, food technology, and other fields requiring precise material delivery systems.
Technical specifications
- Electric and non-electric field driven approaches: Enables versatile encapsulation processes.
- Molecular gates: Facilitates controlled release of payloads.
- Membrane variability: Capable of producing encapsulations with various membrane thicknesses and porosities.
- Scalability: Designed for potential scale-up to deliver materials ranging from molecular sizes upwards.
Technology readiness level
The technology is at TRL 4, indicating that the concept has been validated in a laboratory environment. Future work will focus on release kinetics, scalability, and broader material application validation.
About University College London
University College London is a comprehensive public research university in central London, integrated with major NHS teaching hospitals for clinically embedded research and rapid translation. Co‑located labs, maker spaces, and pilot‑scale facilities span Bloomsbury and the expanding East London campus, offering flexible industry access and residency options. Corporate engagement teams structure sponsored research, secondees, and bespoke consortia to align capabilities with product roadmaps. Research is supported by competitive funding from UK Research and Innovation, the National Institute for Health and Care Research, the Wellcome Trust, and European programs. A dedicated technology transfer company manages IP, licensing, and spinouts, with pathways to seed investment and scale‑up partners.
delivered to your inbox.